Gräber, S. Y., van Mourik, P., Vonk, A. M., Kruisselbrink, E., Hirtz, S., van der Ent, C. K., . . . Beekman, J. M. (2020). Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation. American journal of respiratory and critical care medicine, 202(11), . https://doi.org/10.1164/rccm.202004-1200LE
Chicago-Zitierstil (17. Ausg.)Gräber, Simon Y., Peter van Mourik, Annelotte M. Vonk, Evelien Kruisselbrink, Stephanie Hirtz, Cornelis K. van der Ent, Marcus A. Mall, und Jeffrey M. Beekman. "Comparison of Organoid Swelling and in Vivo Biomarkers of CFTR Function to Determine Effects of Lumacaftor-ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation." American Journal of Respiratory and Critical Care Medicine 202, no. 11 (2020). https://doi.org/10.1164/rccm.202004-1200LE.
MLA-Zitierstil (9. Ausg.)Gräber, Simon Y., et al. "Comparison of Organoid Swelling and in Vivo Biomarkers of CFTR Function to Determine Effects of Lumacaftor-ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation." American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 11, 2020, https://doi.org/10.1164/rccm.202004-1200LE.